Pfizer Inc. is currently sponsoring a study to compare the effectiveness of torcetrapib/atorvastatin to simvastatin (Zocor) in patients with high cholesterol. This national study is currently recruiting patients.
Read moreNational Cholesterol Education Month is coming to a close. We’ve discussed what cholesterol is and how it is measured. We’ve talked... Read more »
Statins (technically, HMG-CoA reductase inhibitors) are a very important class of prescription medications. The drugs in this class... Read more »
“Torcetrapib: the $800 million dollar failure”“Pfizer stock drops 10.6%!”“This spells the death of what is arguably the most... Read more »
This is a study to determine the safety and effectiveness of a new drug, PPAR alpha, and atorvastatin (Lipitor) in treating high cholesterol. This... Read more »
A study published in the British Medical Journal has found that atorvastatin may cause nightmares in some patients. Part of the research detailed the... Read more »
Research published in the journal Urology shows that atorvastatin-aka Lipitor-may help fight bladder cancer. In experiments, the... Read more »
Higher doses of Lipitor (atorvastatin) may help some diabetics who have signs of heart disease, a new study at the University of Glasgow has found.... Read more »
Canadian researchers have developed a combination therapy that may reduce the risk of brain damage from a stroke. The therapy includes atorvastatin... Read more »